Abstract:BACKGROUND: Malignant obstructive jaundice is mainly caused by cholangiocarcinoma. Only a few patients are indicated for surgical resection, and the 3-year survival rate is < 50%. For patients who are not eligible for surgery, biliary stent placement can relieve biliary obstruction and improve liver function and quality of life. However, restenosis after biliary stents has a poor prognosis and is a clinical challenge. Biliary stent combined with iodine-125 (125I) seed implantation can prolong stent patency and improve survival.AIM: To evaluate the safety and efficacy of biliary stent combined with 125I seed strand implantation in malignant obstructive jaundice.METHODS: We enrolled 67 patients between January 2016 and June 2018 with malignant obstructive jaundice and randomized them into a biliary stent combined with 125I seed strand treatment (combined) group (n = 32) and biliary stent (control) group (n = 35). All patients underwent enhanced computed tomography and magnetic resonance imaging and were tested for biochemical and cancer markers. Twelve patients underwent pathological examination before surgery. All patients were followed up by telephone or clinical visit. Postoperative liver function improvement, postoperative complications, stent patency time, and survival time were compared between the two groups. Prognostic risk factors were evaluated.RESULTS: Technical success was achieved in all patients in both groups. Postoperative liver function improved significantly in all patients (total bilirubin, direct bilirubin, alanine aminotransferase, and aspartate aminotransferase decreased significantly in all patients, the P values were less than 0.05). There was no significant difference in preoperative or postoperative indexes between the two groups for changes in total bilirubin (P = 0.147), direct bilirubin (P = 0.448), alanine aminotransferase (P = 0.120), and aspartate aminotransferase (P = 0.387) between the two groups. The median stent patency time of the combined group was 9.0 ± 1.4 mo [95% confidence interval (CI): 6.3-11.8 mo], which was significantly longer than the that of the control group (6.0 ± 0.3 mo, 95%CI: 5.5-6.5 mo, P = 0.000). The median survival time of the combined group was 11.0 ± 1.4 mo (95%CI: 8.2-13.7 mo), which was significantly longer than that of the control group (7.0 ± 0.3 mo, 95%CI: 6.4-7.6 mo, P = 0.000). Location of obstruction and number of stents were independent risk factors affecting prognosis.CONCLUSION: Biliary stent combined with 125I seed strand implantation is safe and effective in malignant obstructive jaundice and improves stent patency time and median survival time.

Damage to Pig Bile Duct Caused by Intraluminal Brachytherapy Using a (125)I Ribbon.

The Use of 125I Seed Strands for Intraluminal Brachytherapy of Malignant Obstructive Jaundice

Intrabiliary Radiofrequency-Enhanced Local Chemotherapeutic Deposit in Bile Duct Walls Using a Needle-Integrated Balloon Catheter: A Feasibility Study on Survival Pigs

Malignant Obstructive Jaundice Treated with Intraluminal Placement of Iodine-125 Seed Strands and Metal Stents: an Analysis of Long-Term Outcomes and Prognostic Features

Comparison of Intraluminal Brachytherapy Combined with and Without Stent Placement for Treatment of Obstructive Jaundice Induced by Tumor Thrombus.

Malignant Obstructive Jaundice Treated by Intraluminal Brachytherapy Combined with Stent Placement or Stent Implantation Alone

Preliminary application of brachytherapy with double-strand 125I seeds and biliary drainage for malignant obstructive jaundice

Iodine-125 Seeds Combined with Biliary Stent Placement Versus Stent Placement Alone for Unresectable Malignant Biliary Obstruction: A Meta-Analysis of Randomized Controlled Trials

Percutaneous Drainage and Stenting for Treatment of Malignant Obstruction of Bile Duct

HDR-^192Ir Intraluminal Brachytherapy in Treatment of Malignant Obstructive Jaundice

Malignant obstructive jaundice - brachytherapy as a tool for palliation

A Pilot Study of Intraluminal Brachytherapy Using 125I Seed Strand for Locally Advanced Pancreatic Ductal Adenocarcinoma with Obstructive Jaundice.

Biliary stent combined with iodine-125 seed strand implantation in malignant obstructive jaundice

Development of a Novel Endovascular Brachytherapy Stent: A Proof-of-concept Study

Development of an Intrabiliary MR Imaging-monitored Local Agent Delivery Technique: A Feasibility Study in Pigs

Biliary stent with or without 125 I seeds for malignant obstructive jaundice : a systematic review and meta-analysis

Experimental Study of 103pd Stents for Preventing the Restenosis of Biliary Duct

Iodine-125 Interstitial Brachytherapy Reduces Tumor Growth Via Warburg Effect Inhibition in Non-Small Cell Lung Cancer A549 ×Enografts.

Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs

Intrabiliary RF Heat-Enhanced Local Chemotherapy of a Cholangiocarcinoma Cell Line: Monitoring with Dual-Modality Imaging--preclinical Study.

Brachytherapy by Percutaneous Paracentesis Implantation of Iodine-125 Seeds for Lung Cancer